Skip to content

Hand Rehabilitation Using Botulinum Toxin and Functional Electrical Stimulation-pilot Study

Hand Rehabilitation Using Botulinum Toxin and Functional Electrical Stimulation Among Stroke Patients With Limitation of Finger Extension Due to Spasticity- Pilot Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03549975
Enrollment
20
Registered
2018-06-08
Start date
2016-05-18
Completion date
2017-08-18
Last updated
2018-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spastic Hemiparesis, Spasticity as Sequela of Stroke, Stroke

Keywords

stroke, hand, botulinum toxin, functional electrical stimulation

Brief summary

The investigator tried to find out possibility of functional improvement using botulinum toxin injection targeting finger flexor spasticity with functional electrical stimulation among chronic stroke patients who did not show any improvement in hand function.

Interventions

DRUGBotulinum Toxin Type A 100 unit/Vial (Product)

Botulinum toxin type A injection followed by functional electrical stimulation

Sponsors

National Rehabilitation Center, Seoul, Korea
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age over 18 years * hemiplegic upper limb spasticity secondary to a unilateral ischemic or hemorrhagic stroke * fingers and wrist flexor spasticity graded at least 1+ on the Modified Ashworth Scale * at least 6 months since stroke

Exclusion criteria

* fixed contracture * previous treatment of the upper limb spasticity with neurolytic or surgical procedure * treatment with botulinum toxin type A in the previous 4 months * any active device implant * any neurological disorder, other than stroke causing motor deficits or spasticity * inability to attend to and/or to cooperate with all outcome measure-related task secondary to cognitive impairment or aphasia * pregnancy, planned pregnancy, or lactation * contraindication to botulinum toxin type A

Design outcomes

Primary

MeasureTime frameDescription
Change in Box and Block testbaseline, 2 weeks after baseline, 6 weeks after baseline, 10 weeks after baselinenumber of box moved by affected upper extremity
Change of Action Research Arm Testbaseline, 2 weeks after baseline, 6 weeks after baseline, 10 weeks after baselineScore of Action Research Arm Test

Secondary

MeasureTime frameDescription
Repeated number of finger extension and flexionbaseline, 2 weeks after baseline, 6 weeks after baseline, 10 weeks after baselineRepeated number of finger extension and flexion
active range of motion of wrist jointbaseline, 2 weeks after baseline, 6 weeks after baseline, 10 weeks after baselineactive range of motion of wrist joint
Brunnstrom stage of stroke recovery of distal upper extremitybaseline, 2 weeks after baseline, 6 weeks after baseline, 10 weeks after baselineBrunnstrom stage of stroke recovery of distal upper extremity. By observing the pattern of participants posture, the stage was scored. The stage ranges from 1 to 6. Higher is better.
Distance from middle finger tip to mid-palmar creasebaseline, 2 weeks after baseline, 6 weeks after baseline, 10 weeks after baselineDistance from middle finger tip to mid-palmar crease
Muscle strength of finger extensorbaseline, 2 weeks after baseline, 6 weeks after baseline, 10 weeks after baselineMedical research council grading of muscle strength
Grading of active thumb oppositionbaseline, 2 weeks after baseline, 6 weeks after baseline, 10 weeks after baselineGrading of active thumb opposition. It is measured by observing the pattern of thumb opposition.
Grip strengthbaseline, 2 weeks after baseline, 6 weeks after baseline, 10 weeks after baselinemeasured by Jamar dynamometer
Active finger extensionbaseline, 2 weeks after baseline, 6 weeks after baseline, 10 weeks after baselineActive finger extension. It is graded by observation of voluntary finger extension.
Quick Disabilities of Arm, Shoulder & Handbaseline, 2 weeks after baseline, 6 weeks after baseline, 10 weeks after baselineQuick Disabilities of Arm, Shoulder & Hand is questionnaire about patients' symptoms as well as ability to perform certain activities in the last week. Total score is obtained by summing the each question, and ranges from 0 (no disability) to 100 (most severe disability).
Spasticity of finger extensorbaseline, 2 weeks after baseline, 6 weeks after baseline, 10 weeks after baselineModified ashworth scale of finger flexor

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026